Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
WuXi Biologics Plans to Expand its Manufacturing Facility in Massachusetts, USA
WuXi Biologics plans to increase its total manufacturing facility in Massachusetts USA The facility is deisgned to increase the total manufacturing capacity 36,000 litres
Xbiotech to Open New Research & Development Facility in USA
Xbiotech plans to start the construction of a new stateoftheart research and development RD facility in the United States The stateoftheart facility, spanning over 46,000 square feet
Lek Invests US$400 mn for the Construction of Biopharmaceutical Production Centre in Slovenia, Europe
Lek will invest US$400 million for the construction of an advanced biopharmaceutical production centre in Slovenia, Europe The facility will feature cuttingedge production and storage facilities
Novartis to Open New Radioligand Therapy Manufacturing Facility in Indiana, USA
Novartis plans to open a new largescale, stateoftheart radioligand therapy RLT manufacturing facility in Indiana,USA The 70,000square foot site dedicated to RLT manufacturing stands
AGC Biologics Invests US$350 bn(¥50bn) to Construct New Manufacturing Site in Yokohama, Japan
AGC Biologics plans to construct a new manufacturing facility in Yokohama Japan The new facility, spanning four storeys and 20,000 square metres
Rentschler Biopharma to Open New Biopharma Manufacturing Facility in Massachusetts, USA
Rentschler Biopharma plans for the new biopharma manufacturing centre RBMC facility at its manufacturing site in Massachusetts, USA
BioNTech Invests US$150 million to Build mRNA Vaccine Manufacturing Facility in Rwanda, Africa
BioNTech is investing US$150 million to establish an mRNA vaccine manufacturing facility in Rwanda, Africa
BiomeBank Plans to Open a New State-of-the-Art GMP Facility in Adelaide, Australia
BiomeBank plans to open a new good manufacturing practise GMP facility to advance biomedical research and production in Adelaide, Australia
FUJIFILM Diosynth Biotechnologies Unveils US$200 million to Open New Manufcaturing Capacity in USA
FUJIFILM Diosynth Biotechnologies invests US$200 million to open new facility to expand cell therapy capabilities in USA
Full-Life Technologies Commences Construction on State-of-the-Art GMP Manufacturing Facility in Belgium, Europe
FullLife Technologies breaks ground for GMP manufacturing facility to advance its endtoend solution for radiopharmaceuticals in Belgium, Europe
